[Form 4] Bunge Global SA Insider Trading Activity

Rhea-AI Filing Summary

Christopher Mahoney, a director of Bunge Global SA (BG), reported a purchase of 5,000 shares of the company's common stock on 08/18/2025 at a weighted average price of $81.73 per share, increasing his beneficial ownership to 7,164 shares. The filing notes the purchase was executed in multiple trades at prices ranging from $81.69 to $81.75. No derivative transactions were reported. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Director purchase reported: Christopher Mahoney acquired 5,000 shares, showing personal investment in the company

Negative

• None.

Insights

Financial Analyst

TL;DR Insider purchase of 5,000 BG shares at $81.73 increases director ownership modestly; size suggests limited immediate market impact.

The reported purchase is a straightforward open-market acquisition by a company director. The weighted average price and narrow trade range indicate execution over a short time window. Without information on total outstanding shares or the director's historical trading pattern, the transaction appears routine and unlikely to be material to BG's valuation by itself. Investors may note insider alignment but should not infer broader corporate developments from this single Form 4.

Corporate Governance Expert

TL;DR A director-level purchase signals personal investment in BG but lacks disclosed size context to assess governance implications.

Director Christopher Mahoney’s acquisition is properly disclosed and executed within a tight price band, suggesting compliance with disclosure rules. The filing contains no indicia of 10b5-1 plan usage and lists no derivatives or indirect ownership structures. From a governance standpoint, the action is positive for alignment but not demonstrably material to control or strategic direction based on the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mahoney Christopher

(Last) (First) (Middle)

C/O BUNGE GLOBAL SA

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD MO 63017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		P		5,000	A	$81.73(1)	7,164	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $81.69 to $81.75. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

Remarks:

	/s/ Drew Yaeger, Attorney-in-Fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Christopher Mahoney report buying in the Form 4 for BG?

He purchased 5,000 shares of Bunge Global SA common stock on 08/18/2025 at a weighted average price of $81.73 per share.

How many shares does the reporting person beneficially own after the transaction?

7,164 shares beneficially owned following the reported purchase.

Were any derivative transactions reported in this Form 4 for BG?

No derivative securities were reported in Table II; only a non-derivative common stock purchase is listed.

What price range did the trades execute at in the reported BG purchase?

Trades executed at prices ranging from $81.69 to $81.75; the filing reports a weighted average of $81.73.

When was the Form 4 signed and by whom?

The filing bears a signature by an attorney-in-fact (Drew Yaeger) dated 08/20/2025 on behalf of the reporting person.